Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Deborah Collyar: What's In It for Patients?

Advertisement

Advertisement




Jun
04
Today In Oncology
Annual Galleri Screening Reduced Stage IV Cancer Diagnoses but Missed Primary Endpoint in First Randomized MCED Trial
GLP-1 RAs Associated With Lower Breast Cancer Incidence
American Cancer Society Updates Colorectal Cancer Screening Guideline
Long-Term Follow-Up of Three First-Line Regimens in Mantle Cell Lymphoma
Does Tissue TMB Outperform Blood-Based Testing for Predicting Immunotherapy Response
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo